Skip to main content

Find Clinical Trials

Home
Conditions
Refractory Endometrial Carcinoma

Clinical trial condition

Refractory Endometrial Carcinoma

Explore clinical trials studying Refractory Endometrial Carcinoma. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Refractory Endometrial Carcinoma trial results

Recruiting

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

NCT05039801

Conditions: Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, +71 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer

NCT04719273

Conditions: Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations: Jefferson Abington Hospital Abington, Pennsylvania, United States

Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma

NCT03008408

Conditions: Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +22 more
Locations: Lyndon Baines Johnson General Hospital Houston, Texas, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details